Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-time Usage of SGLT2 Inhibitors in Type 2 Diabetic Patients Who Are Fasting During Ramadan: Safety and Efficacy

NCT06370247 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT06370247
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06370247 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-time Usage of SGLT2 Inhibitors in Type 2 Diabetic Patients Who Are Fasting During Ramadan: Safety and Efficacy
Lead sponsor
Sohag University
Phase
Not applicable
Overall status
Completed
Start date
April 25, 2023
Completion date
September 25, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fasting in ramadan, sglt2 inhibitors, first time use, type2 diabetes